Showing results (2381-2390 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|March 17, 2007
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumorsMartee L Hensley, Don Dizon, Felicia Derosa, et al.
Investigational New Drugs|February 1, 1991
Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group studyJ A Kish, K Kopecky, M K Samson, et al.
Investigational New Drugs|June 10, 2006
Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignanciesHervé Ghesquières, Sandrine Faivre, Latifa Djafari, et al.
Investigational New Drugs|November 15, 2006
Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumorsS Kalmadi, M Davis, A Dowlati, et al.
Investigational New Drugs|November 29, 2008
Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosisAnsgar Brüning, Petra Burger, Marianne Vogel, et al.
Investigational New Drugs|November 15, 2008
The fungal secondary metabolite trichodimerol inhibits TGF-β dependent cellular effects and tube formation of MDA-MB-231 cellsAnnegret Serwe, Timm Anke, Gerhard Erkel
Investigational New Drugs|November 13, 2008
Extracts of marine sponge Polymastia janeirensis induce oxidative cell death through a caspase-9 apoptotic pathway in human U138MG glioma cell lineMario Luiz Conte da Frota, Elizandra Braganhol, Andrés Delgado Canedo, et al.
Investigational New Drugs|June 26, 2009
Nelfinavir induces mitochondria protection by ERK1/2-mediated mcl-1 stabilization that can be overcome by sorafenibAnsgar Brüning, Petra Burger, Marianne Vogel, et al.
Investigational New Drugs|July 3, 2009
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumorsRadharani Gollamudi, Mohammad H Ghalib, Kavita K Desai, et al.
Investigational New Drugs|July 8, 2009
Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal modelThilo S Lange, Ashley R Stuckey, Katina Robison, et al.
Pageof 372